Fritextsökning
Innehållstyper
-
Pfizer varslar – omstrukturerar den nordiska verksamheten
Pfizer genomför ännu en omorganisation av sin nordiska verksamhet. I Sverige, Danmark och Norge innebär det personalminskningar.
-
Study names with an attitude – more important than you might think
Ironman, T-rex, Star-Trek. Popcorn, Proper, Scout. Nope, these are neither fantasy films nor dog names. They’re the names of ongoing cancer studies in Sweden.
-
Pila Pharma tar in 20 miljoner kronor – inleder ”dedikerat fetmaspår”
Malmöbolaget Pila Pharma utvecklar ett nytt, oralt läkemedel för behandling av typ 2-diabetes. Ett nytt kapitaltillskott ska användas för att initiera studier o...
-
Aurevia
-
Scientific Solutions
-
CTC Clinical Trial Consultants AB
-
Pharma Outsourcing – Find the Right Partner (2026)
-
Galderma
-
Setback for pharmaceutical companies in the Zantac case
A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.
-
Elevating 3D characterization with enhanced performance and efficiencies
Introducing the ZEISS VersaXRM 730 3D X-ray microscope.
-
Zelmic
-
QPS Netherlands B.V
-
About Microscope Ergonomics
Learn about ergonomic microscope design and how you can increase your well-being and productivity when working in clinical microscopy. Read about challenges, de...
-
Metabolon
-
Xbrane tar in 240 miljoner – satsar vidare på biosimilarprojekt
Biosimilarutvecklaren Xbrane Biopharma tar in 240 miljoner kronor i en riktad nyemission, som var övertecknad.
-
Cost-efficient development of laboratory devices
8 ways to optimise development costs and speed up processes
-
New cell therapy raises hope for curing type 1 diabetes – "Never succeeded before"
For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified insulin-producing cells that do not require...
-
WuXi Biologics Germany GmbH
-
Abbvie i miljardaffär – tar sikte på in vivo CAR-T
Abbvie har tecknat avtal om att förvärva det kliniska biotechbolaget Capstan Therapeutics för upp till 2,1 miljarder dollar och får därmed tillgång till bland a...
-
Moderna develops mRNA vaccine against norovirus
A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...
-
Danish obesity success causes recruitment problems in southern Sweden
The substantial expansion of Danish Novo Nordisk is affecting companies in southern Sweden, which are finding it increasingly difficult to compete for attractive staff.
-
Meribel Pharma Solna
-
A+ Science AB
-
Hypothesis testing versus conspiracy theory
"How do you know what is a conspiracy theory and what is a reasonable, scientifically based conclusion?" In a column, Ingrid Lönnstedt reflects on this question.